37results about How to "Prevent acidosis" patented technology

The invention discloses a late compound feed for improving the body shape and meat quality of fattening pigs and a processing method thereof, belonging to the technical field of feed. The later stage feed is formulated with the following raw materials in mass percentage: 0.2-0.4% of betaine, 0.02-0.05% of chromium pyridine carboxylate, 0.01-0.02% of yeast selenium, 0.01-0.02% of vitamin E, and 0.01-0.03% of vitamin C , magnesium sulfate 0.06‑0.10%, potassium chloride 0.1‑0.2%, corn 64.0‑66.0%, soybean meal 20.0‑22.0%, oil bran 5.0‑6.0%, palm oil 0.8‑1.0%, coarse bran 4.0‑6.0%, Calcium hydrogen phosphate 0.38‑0.50%, stone powder 1.05‑1.20%, sodium chloride 0.40‑0.45%, antioxidant 0.05‑0.07, premix 1.0%.

The invention discloses a tumor tissue preservation solution and its application. The primary tumor tissue preservation solution of the invention does not contain serum, has definite components and little difference between batches. BSA, trehalose, γ‑polyglutamic acid, linoleic acid and other components are used in combination to synergize, which can effectively overcome cellular acidosis, edema and external physical stress caused by long-term transportation and storage conditions, thus Reduce cell damage, maintain tissue morphology and cell viability. With the prolongation of storage time, the decline of cell viability of cancer tissue slows down. need.

The invention discloses a medicine for preventing and curing forestomach atony of ruminants, being prepared with the medicines according to a certain proportion: (fried) nuxvomica, areca seed, pharbitidis seed, euphorbia root, medicated leaven, hawthorn fruit, malt, Chinese rhubarb, mirabilite, stertite, antimony potassium tartrate and sodium bicarbonate, which (except mirabilite and stertite) are sun-dried, purified, crushed, and then grinded with two western medicines, sieved through an 80 to 100-mesh screen and finally mixed evenly. In clinical practice, the medicines are socked in boiled water for 30-60 minutes, of which the effective ingredients are dissolved and precipitated for improving the absorption rate of the medicine which is one-time drenched when cool. The medicine of the invention has quicker efficacy and smaller dosage compared with the single use of traditional Chinese medicine, longer maintenance time of drug effect and more difficult recurring compared with the single use of western medicine, and is difficult to develop the immunity to drugs, effectively releases or eliminates in vivo metabolic acidosis, greatly reduces death rate without a untoward reaction and with higher clinic cure rate. With simple preparation method and convenient use, the invention can be widely used in the breeding industry.

The invention discloses a feed for feeding beef cattle in a grassless manner and a preparation method of the feed and relates to the technical field of feeds. The feed is prepared from the following raw materials in parts by weight: 450-600 parts of corn, 50-200 parts of corn gluten meal, 100-200 parts of bean pulp, 30-40 parts of palm oil at 52 DEG C, 10-20 parts of maintain flour, 5-15 parts of calcium hydrogen phosphate, 6-8 parts of salt, 12-22 parts of baking soda, 3-6 parts of magnesium oxide, 1-3 parts of ammonium chloride, 0.03-0.07 part of chromium picolinate, 2-4 parts of medicated leaven, 2-6 parts of malt, 4-6 parts of haws, 2-4 parts of scutellaria baicalensis, 2-4 parts of herba artemisiae scopariae, 2-3 parts of rumen-protected lysine, 1-2 parts of rumen protected methionine, 0.2-1 part of a special enzyme for beef cattle, 1-2 parts of special trace elements for beef cattle and 0.2-0.4 part of special vitamins for beef cattle. The raw materials are uniformly mixed to prepare the feed. The feed disclosed by the invention is high in energy content and high in feed conversion ratio, the fattening period is shortened, the feeding cost is lowered, and the income of the raising households is increased.

Disclosed are intravenous hypertonic electrolyte solutions for treating intracranial hypertension while reducing the risk of inducing hyperchloremic metabolic acidosis. The solutions are characterized by a ratio of sodium-to-chloride (Na:Cl) ions of 1.2-1.6 and a total osmolarity of 310-400 mEq / L for a maintenance solution, and a total osmolarity greater than 1000 mEq / L for an initiation solution.